In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

International Regulatory Consultation

Great rewards are available when you conduct clinical development programs on a global basis. But to collect your reward, you may have to run a gauntlet of international regulatory agencies. PharmaNet Consulting professionals offer experience with regulatory agencies on 5 continents. Whether you need advice on submissions to Canada’s HPFB or help arranging a meeting with Brazil’s ANVISA, PharmaNet professionals have the experience to assist you.

 

PharmaNet professionals available for consultation on this topic include:

 

Andrew Chang, PhD

Executive Director, PharmaNet Consulting

 

Bengt Danielsson, MD, PhD

Vice President, PharmaNet Consulting


William M. Egan, PhD

Vice President, PharmaNet Consulting


Joyce Lea Frey-Vasconcells, PhD

Executive Director, PharmaNet Consulting


Gregory M. Hockel, MBA, PhD

Senior Vice President, Regulatory Affairs Worldwide


Mary F. Johnson, PhD

Executive Vice President, Biostatistics


Mario Tanguay, BPharm, PhD

Vice President, Scientific and Regulatory Affairs, Anapharm


Duu-Gong Wu, PhD

Executive Director, PharmaNet Consulting

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390